Evidence map›Paper›PMID 38264932›Full record

SynthesisClinical and translational medicine2024

Crosstalk between fibroblasts and immunocytes in fibrosis: From molecular mechanisms to clinical trials.

Xingpeng Di, Jiawei Chen, Ya Li, Menghua Wang, Jingwen Wei, Tianyue Li, Banghua Liao, Deyi Luo

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Clinical and translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. RIPK3 Orchestrates Scar-Associated Macrophage Dysfunction to Drive Pulmonary Fibrosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Scar wars: the viral menace.American journal of physiology. Lung cellular and molecular physiology · 2025
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Xingpeng DiDepartment of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, P.R. China.ORCID 0000-0002-1921-5509
Jiawei ChenDepartment of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, P.R. China.ORCID 0000-0002-0607-6351
Ya LiDepartment of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, P.R. China.ORCID 0000-0002-4795-3146
Menghua WangDepartment of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, P.R. China.ORCID 0000-0003-2670-6434
Jingwen WeiDepartment of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, P.R. China.ORCID 0000-0003-4436-3527
Tianyue LiDepartment of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, P.R. China.
Banghua LiaoDepartment of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, P.R. China.
Deyi LuoDepartment of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, P.R. China.ORCID 0000-0002-9436-036X
Sichuan University · CN

Funding

National Natural Science Foundation of China 32171301National Natural Science Foundation of China 82270720National Postdoctoral Researcher Program of China GZC20231800Project of Science and Technology Department of Sichuan Province 2015SZ0230-2Project of Science and Technology Department of Sichuan Province 2023YFS0029Project of Science and Technology Department of Sichuan Province 24NSFSC3172
6 · The paper itself

Abstract

backgroundThe impact of fibroblasts on the immune system provides insight into the function of fibroblasts. In various tissue microenvironments, multiple fibroblast subtypes interact with immunocytes by secreting growth factors, cytokines, and chemokines, leading to wound healing, fibrosis, and escape of cancer immune surveillance. However, the specific mechanisms involved in the fibroblast-immunocyte interaction network have not yet been fully elucidated. MAIN BODY AND

conclusionTherefore, we systematically reviewed the molecular mechanisms of fibroblast-immunocyte interactions in fibrosis, from the history of cellular evolution and cell subtype divisions to the regulatory networks between fibroblasts and immunocytes. We also discuss how these communications function in different tissue and organ statuses, as well as potential therapies targeting the reciprocal fibroblast-immunocyte interplay in fibrosis. A comprehensive understanding of these functional cells under pathophysiological conditions and the mechanisms by which they communicate may lead to the development of effective and specific therapies targeting fibrosis.

Indexed as

CytokinesFibroblastsCell DivisionCross ReactionsFibrosisHumansCytokinesfibroblastfibrosisimmunocytemolecular mechanismtherapy

Identifiers

PMID38264932
PMCPMC10807359
OpenAlexW4391174472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.